Bacitracin and Gastroesophageal reflux disease - a phase IV clinical study of FDA data

Summary:

Gastroesophageal reflux disease is reported as a side effect among people who take Bacitracin (bacitracin), especially for people who are male, 50-59 old, also take Zometa, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Gastroesophageal reflux disease when taking Bacitracin. It is created by eHealthMe based on reports of 1,207 people who have side effects when taking Bacitracin from the FDA, and is updated regularly.

What is Bacitracin?

Bacitracin has active ingredients of bacitracin. eHealthMe is studying from 1,214 Bacitracin users. Check the latest studies of Bacitracin.

What is Gastroesophageal reflux disease?

Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus) is found to be associated with 2,396 drugs and 3,490 conditions by eHealthMe. Check the latest studies of Gastroesophageal reflux disease.

On Jul, 11, 2026

1,207 people reported to have side effects when taking Bacitracin.
Among them, 36 people (2.98%) have Gastroesophageal reflux disease.

Could Bacitracin cause Gastroesophageal reflux disease?

Among these 36 people:

What is the gender of people who have Gastroesophageal reflux disease when taking Bacitracin? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Gastroesophageal reflux disease when taking Bacitracin? *

What are other drugs people take besides Bacitracin? *

What are other side effects people have besides Gastroesophageal reflux disease? *

Pain: 26 people, 72.22%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 25 people, 69.44%
Dyspnea (difficult or laboured breathing): 24 people, 66.67%
Stress And Anxiety: 24 people, 66.67%
Osteonecrosis Of Jaw (death of bone of jaw): 23 people, 63.89%
Joint Pain: 23 people, 63.89%
Pneumonia: 23 people, 63.89%
Anaemia (lack of blood): 22 people, 61.11%
Deformity (disfigurement): 21 people, 58.33%
Pain In Jaw: 21 people, 58.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 15 people, 41.67%
Metastases To Prostate (cancer spreads to prostate): 5 people, 13.89%
Metastases To Bone (cancer spreads to bone): 5 people, 13.89%
Breast Cancer: 4 people, 11.11%
Pain: 3 people, 8.33%
Diabetes: 3 people, 8.33%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 5.56%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 2.78%
Diarrhea: 1 person, 2.78%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 2.78%

* Approximation only. Some reports may have incomplete information.

Do you take Bacitracin and have Gastroesophageal reflux disease?

- Check whether Gastroesophageal reflux disease is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bacitracin:

Bacitracin (1,214 reports)

Browse all side effects of Bacitracin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gastroesophageal reflux disease:

Gastroesophageal reflux disease (2,396 drugs)

Browse all the conditions that are associated with Gastroesophageal reflux disease:

Gastroesophageal reflux disease (3,490 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bacitracin (the active ingredients of Bacitracin) and Bacitracin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.